Dr. Carrillo has a wide range of responsibilities, including oversight of the Association's granting process and communication of scientific findings within and outside of the organization. Dr. Carrillo is responsible for overseeing the international science division for the Alzheimer’s Association and is responsible for sharing the global landscape of research and ongoing investigations with a wide range of constituents. Dr. Carrillo also manages several Association initiatives. One of these is the Alzheimer's Association International Conference, the largest international discussion on Alzheimer’s and related dementias in the world. Another is the Alzheimer’s Association Research Roundtable, which provides a forum for pharmaceutical companies to discuss trends in Alzheimer research and therapeutic targets. Other Association programs managed by Dr. Carrillo include the management of the World-Wide Alzheimer’s Disease Neuroimaging Initiative (WW-ADNI), which is a multi-country research effort aimed at finding biomarkers for early detection of Alzheimer’s, Dr. Carrillo is a member of the Genworth Financial Medical Advisory Board and an Advisory Committee member for The Shriver Report, and co-editor of Modernizing the Diagnosis of Alzheimer’s Disease. Dr. Carrillo is also co-author of the NIA-AA revised criteria, and Appropriate Use Criteria for Amyloid Imaging. Dr. Carrillo has published extensively in the area of Alzheimer’s disease on early diagnosis and biomarker standardization efforts, in addition to global challenges to progress for research in Alzheimer’s and dementia. Dr. Carrillo is the Alzheimer’s Expert Scientific Consultant for the movie Still Alice (2014).